Concepedia

Ana Galan Cobo

AG

13

Publications

2.4K

Citations

12

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Instituto de Biomedicina de Sevilla

Hospital Universitario Virgen del Rocío

Universidad de Sevilla

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

Ana Galan Cobo is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and cellular physiology.

ORCID

Top concepts

Publications per year

2013–2025

13

Publications

13

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.5K citations · Full text

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in <i>KRAS</i> -Mutant Lung Adenocarcinoma

Ana Galan Cobo, Piyada Sitthideatphaiboon, Xiao Qu et al. · Cancer Research · 2019 · 265 citations · Full text

MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

Yu Qian, Ana Galan Cobo, Irene Guijarro et al. · Cancer Cell · 2023 · 153 citations · Full text

, , +7

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong et al. · Nature · 2024 · 117 citations · Full text

<i>STK11</i> /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition

Piyada Sitthideatphaiboon, Ana Galan Cobo, Marcelo V. Negrão et al. · Clinical Cancer Research · 2020 · 108 citations · Full text

Rows per page

1–5 of 13